Jordi Gratacós Ginès (@jordigratacos8) 's Twitter Profile
Jordi Gratacós Ginès

@jordigratacos8

Liver Unit, Hospital Clínic de Barcelona

ID: 1740325223038177280

calendar_today28-12-2023 10:54:46

19 Tweet

69 Followers

76 Following

Ramon Bataller (@rabataller) 's Twitter Profile Photo

Recurrent alcohol-associated hepatitis is common and has increased mortality. An important message to our patients. Large study from the REHALC cohort from the Asociación Española para el Estudio del Hígado led by ELISA POSE and Jordi Gratacós Ginès shorturl.at/kvzGX #LiverTwitter AASLD

Recurrent alcohol-associated hepatitis is common and has increased mortality. An important message to our patients.

Large study from the REHALC cohort from the <a href="/AEEHLiver/">Asociación Española para el Estudio del Hígado</a> led by <a href="/PoseElisa/">ELISA POSE</a> and <a href="/JordiGratacos8/">Jordi Gratacós Ginès</a> 

shorturl.at/kvzGX #LiverTwitter <a href="/AASLDtweets/">AASLD</a>
JHEP Reports (@jhep_reports) 's Twitter Profile Photo

🟪NEW Article in press❕ Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-… #LiverTwitter

🟪NEW Article in press❕

Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology

 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-…

#LiverTwitter
Aleksander Krag (@aleksanderkrag) 's Twitter Profile Photo

LiverAim Family photo Innovative Health Initiative Party time over - time to activate the 25M€ invested in the project- 👉measure numerous biomarkers in +30K people for diagnostic and prognostic and 👉validation in an RCT with 100K in Europe - public- private partnerships💪 EASLnews

<a href="/LiverAim/">LiverAim</a> Family photo <a href="/IHIEurope/">Innovative Health Initiative</a> 
Party time over - time to activate the 25M€ invested in the project- 👉measure numerous biomarkers in +30K people for diagnostic and prognostic and 👉validation in an RCT with 100K in Europe - public- private partnerships💪
<a href="/EASLnews/">EASLnews</a>
Hospital Clínic (@hospitalclinic) 's Twitter Profile Photo

🗣️ “Tinc estudis superiors, una feina d’èxit, família i corro maratons. Això li pot passar a qualsevol” 🏥 Descobreix la història d’en Javier, un pacient del #CLÍNIC amb trastorn per ús d'alcohol ➕Info 👉 tinyurl.com/5xc5z5ck

Núria Fabrellas (@fpnuria) 's Twitter Profile Photo

La prevenció de les malalties és clau. Tingues cura del teu fetge! La prevención de las enfermedades es clave. Cuida de tu hígado! Disease prevention is key to your health. Take care of your liver. Asociación Española para el Estudio del Hígado LiverAim LiverScreen H2020 EASLnews @ELPA Mayo Clinic

La prevenció de les malalties és clau. Tingues cura del teu fetge! 
La prevención de las enfermedades es clave. Cuida de tu hígado!
Disease prevention is key to your health. Take care of your liver.  <a href="/AEEHLiver/">Asociación Española para el Estudio del Hígado</a> <a href="/LiverAim/">LiverAim</a> <a href="/Liver_Screen/">LiverScreen H2020</a> <a href="/EASLnews/">EASLnews</a> @ELPA <a href="/MayoClinic/">Mayo Clinic</a>
JHEP Reports (@jhep_reports) 's Twitter Profile Photo

🟪NEW Article in press❕ LIVER FIBROSIS SCREENING INCREASES ALCOHOL ABSTINENCE 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-… #LiverTwitter #ALD

🟪NEW Article in press❕

LIVER FIBROSIS SCREENING INCREASES ALCOHOL ABSTINENCE 

 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-…

#LiverTwitter 
#ALD
ELISA POSE (@poseelisa) 's Twitter Profile Photo

🔎Liver fibrosis screening in addiction units is feasible✅ and enables early diagnosis of ALD 🎉Congratulations Queralt Herms on a great presentation and accomplishment🏆 🚨More info: jhep-reports.eu/article/S2589-… #LiverTwitter #UEGWeek #UEGjournal Jordi Gratacós Ginès

🔎Liver fibrosis screening in addiction units is feasible✅ and enables early diagnosis of ALD

🎉Congratulations <a href="/queraltherms/">Queralt Herms</a> on a great presentation and accomplishment🏆

🚨More info: jhep-reports.eu/article/S2589-…

#LiverTwitter #UEGWeek #UEGjournal <a href="/JordiGratacos8/">Jordi Gratacós Ginès</a>
Maja Thiele (@majathiele) 's Twitter Profile Photo

New expert statement is a treasure chest for ALD+AUD trials: 🎯Recommendations for definitions, incl & excl, endpoints, NITs, etc 👉Alcohol drinking limits confuses: discrepancy btw NIAAA, WHO, SLD consensus 🔗rdcu.be/dXw7W Nature Reviews Gastroenterology & Hepatology Ramon Bataller @KatieWitkiewitz

New expert statement is a treasure chest for ALD+AUD trials:
🎯Recommendations for definitions, incl &amp; excl, endpoints, NITs, etc
👉Alcohol drinking limits confuses: discrepancy btw NIAAA, WHO, SLD consensus
🔗rdcu.be/dXw7W
<a href="/NatRevGastroHep/">Nature Reviews Gastroenterology & Hepatology</a> <a href="/rabataller/">Ramon Bataller</a> @KatieWitkiewitz
Jordi Gratacós Ginès (@jordigratacos8) 's Twitter Profile Photo

📈 MetALD has been gaining interest in the past year 🚨 Check out our comprehensive review on the topic, in press in JHEP Reports: jhep-reports.eu/article/S2589-… 💪 Big thanks to all authors❗ Ramon Bataller ELISA POSE #MetALD #LiverTwitter

Asociación Española para el Estudio del Hígado (@aeehliver) 's Twitter Profile Photo

📣 Se acerca el #DiaMundialsinAlcohol. En todas las Semanas de las Enfermedades Hepáticas hemos abordado este tema con actividades de concienciación enfocadas en la #prevención. Nuestra guía es el Plan Nacional de Salud Hepática y nuestra evidencia, el Registro de Alcohol AEEH.

Eric Topol (@erictopol) 's Twitter Profile Photo

New NEJM A whopping (~90%) reduction of progression to Type 2 diabetes with tirzepatide (GLP-1 drug, dual receptor) vs placebo in a randomized trial of >2,500 participants with obesity, absolute reduction of 10/100 treated nejm.org/doi/full/10.10… by Ania M. Jastreboff, MD, PhD and

New <a href="/NEJM/">NEJM</a> 
A whopping (~90%) reduction of progression to Type 2 diabetes with tirzepatide (GLP-1 drug, dual receptor) vs placebo in a randomized trial of &gt;2,500 participants with obesity, absolute reduction of 10/100 treated
nejm.org/doi/full/10.10…
by <a href="/AniaJastreboff/">Ania M. Jastreboff, MD, PhD</a> and
LiverAim (@liveraim) 's Twitter Profile Photo

🚨 The first webinar of the #LIVERAIM series is approaching! Joinn us and discover how this project is going to revolutionize #earlydiagnosis and management of #chronicliverdisease! 🗓️ 12th Dec 17:30-18:15 CET 📢 Register now! t.ly/yZTI8 #livertwitter #screening

🚨 The first webinar of the #LIVERAIM series is approaching!
Joinn us and discover how this project is going to revolutionize #earlydiagnosis and management of #chronicliverdisease!

🗓️ 12th Dec 17:30-18:15 CET

📢 Register now! t.ly/yZTI8
#livertwitter #screening
JHEP Reports (@jhep_reports) 's Twitter Profile Photo

Liver stiffness measurement predicts clinical outcomes in autoimmune #hepatitis 🔓#OpenAccess at👉jhep-reports.eu/article/S2589-… #livertwitter Maria Carlota Londoño

Liver stiffness measurement predicts clinical outcomes in autoimmune #hepatitis

🔓#OpenAccess at👉jhep-reports.eu/article/S2589-…

#livertwitter 
<a href="/macarlotal/">Maria Carlota Londoño</a>
Ramon Bataller (@rabataller) 's Twitter Profile Photo

So proud to work with the amazing people of the Liver Unit in the Hospital Clinic, Barcelona. Your positive energy and professionalism have an enormous impact in our patients.

So proud to work with the amazing people of the Liver Unit in the Hospital Clinic, Barcelona.

Your positive energy and professionalism have an enormous impact in our patients.
LiverAim (@liveraim) 's Twitter Profile Photo

🚀Launching the #LiverRiskScore app! 📱A simple digital tool to spot liver disease risk early using routine clinical data! Easy to use, built for everyday care. 🔗iOS: apps.apple.com/us/app/liverri… 🔗Android play.google.com/store/apps/det… Innovative Health Initiative EASLnews